◼ Archived
Business
Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags
Kyverna advances its cell therapy toward an FDA submission as new one-year durability data emerges.
Car T-Cell Therapy
3 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
3-year-old boy’s quick-spreading cancer is cured thanks to 2 doses of new treatment
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 holds ✗
Cell therapy substantially reduces severe rheumatoid arthritis in first clinical trial
A first-of-its-kind clinical trial demonstrates that CAR T-cell therapy can put severe rheumatoid arthritis into remission.